Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.
about
Management of insect sting hypersensitivity: an updateMast Cell Clonal Disorders: Classification, Diagnosis and ManagementAnaphylaxis to insect venom allergens: role of molecular diagnosticsRisk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization StatementHymenoptera Allergy and Mast Cell Activation Syndromes.Mast cell activation syndromes: definition and classification.Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment.Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivityLong-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Insect stings: clinical features and management.Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom.Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.Clinical immunology review series: an approach to desensitization.Hymenoptera venom immunotherapy.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Insect allergy.Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature.Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disordersSpectrum of mast cell activation disorders.Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.Immunology of Bee Venom.NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.The Epidemiology of Anaphylaxis.Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrations.Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis.Mastocytosis in children and adults: clinical disease heterogeneityGene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy.Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker.Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy.Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase.[Sting challenge: indications and execution].
P2860
Q24631273-F1126E16-8157-431F-B9FD-012F6E441B0CQ28070386-8AD9194C-0109-40DE-9006-96B899D0253DQ28088677-8C03F1A0-1167-4D4E-AD89-DFD54C0219D0Q30371972-3F4D533F-6DE1-4A1F-9EED-A762F4FDCB6CQ33166619-B423A5BF-6142-44F7-B0F8-C3DD7D927BE6Q34035582-7A9BEB11-93BB-4EC9-A29D-C88DD7897753Q34192110-05113E3B-0EB0-4DEC-ACE0-AC4681E1469EQ34735017-D12D1D77-E592-4EB8-8F3D-91AA66B7D933Q35153623-00E1FBC1-7212-42FA-9836-0D1839286EE1Q35907982-7AB41640-E7C3-479C-86C4-1A0FC3E83B59Q37355616-D0AB6902-B4B2-4143-A9D7-7B66B4D26ECDQ37810130-1E9EF790-247A-4D36-8F0E-A8256FE5F26AQ37822834-D99B97B7-89B7-4DC9-98F1-79590F841CC5Q37842330-B5991F99-0702-4B4D-BDDC-8C99942FA25AQ37873485-67103935-042C-4F36-BB42-4D3DA2B7633FQ37931150-C1F61819-3D8D-44B4-A88E-3FAB3233D862Q37957219-7BB189D3-6089-4D59-B0A7-BC97A246986BQ38202204-AE313FFA-ABFF-4F05-9E31-375CA5E59D45Q38208377-FB8D244D-6456-4D6F-837C-701B9695BF3EQ38504083-4322D943-9411-46B2-9F40-8BB5BBD8EDDEQ39096069-3CBD374B-C894-480E-886C-B279B524E2B2Q39348704-6500E94F-E328-4EEE-A910-F41D44ABCA60Q39779573-F38A276A-B03C-4B62-9E26-2D1607EC562CQ40552110-589B9654-00D2-4D2E-AF9F-E70602B6B04EQ40582052-69E12CA5-441B-4170-AF6E-9110194FC6EDQ40808699-D5FD4E5C-0E16-4454-AEEE-32352BC049EEQ42243338-9B266BBA-C2C0-4625-8AD9-3C7BF82BD08FQ42923350-5A08829A-953B-4484-8207-A6C16CCD7730Q44459579-AEE7E9C0-5697-43F7-893A-4CF0C21D4442Q44928919-7A038019-5057-49DF-8127-78DDAAD21304Q48705226-CFC6CFC0-7AF9-4A06-BE34-B4CAADF7E73EQ50871797-D54BD46E-E8A9-4AD3-A6B3-DE3D936120F6Q51533907-63F43F5A-8C9A-4DA8-9667-5DC07AC5E4BEQ51624794-2A68A33C-3BA9-4477-9A65-27EEEA970547Q52731268-CEBA7B55-2C4A-4B95-8081-D3E7677E2737Q52765228-D8C5FDFA-F961-4FAF-AD68-8896B396D6C1Q52779212-51B0763B-B9C6-4064-8387-201DF5F5BAC6
P2860
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@en
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@nl
type
label
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@en
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@nl
prefLabel
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@en
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@nl
P2093
P2860
P921
P1433
P1476
Mastocytosis and insect venom ...... ficacy of venom immunotherapy.
@en
P2093
J J van Doormaal
J N G Oude Elberink
J de Monchy
M Niedoszytko
P2860
P304
P356
10.1111/J.1398-9995.2009.02118.X
P577
2009-07-21T00:00:00Z